SCHEMBL4342175

SCHEMBL4342175

CC12CN(C(=O)c3ccc4c(c3)OCO4)CC(C)(CN(C(=O)c3ccc4c(c3)OCO4)C1)C2

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.62
ALDH1A1 P00352 6/20 0.62
HSD17B10 Q99714 2/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
CYP2D6 P10635 1/20 0.61
CYP2C9 P11712 1/20 0.61
CYP2C19 P33261 1/20 0.61
GAA P10253 1/20 0.56
KMT2A Q03164 1/20 0.54
TSHR P16473 2/20 0.53
GFER P55789 1/20 0.53
POLB P06746 2/20 0.53
NPC1 O15118 1/20 0.52
TP53 P04637 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
MAPK1 P28482 1/20 0.51
LMNA P02545 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4347843 0.91 HPGD (0.61) HPGDALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL4353434 0.84 HPGD (0.61) HPGDALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL4815471 0.82 HPGD (0.66) HPGDALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL4815481 0.82 HPGD (0.66) HPGDALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL4345772 0.80 HPGD (0.43) HPGDALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL108225 0.80 ALDH1A1 (0.90) HPGDALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL4353493 0.80 HPGD (0.43) HPGDALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL4343757 0.79 HPGD (0.42) HPGDALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL4345617 0.79 HPGD (0.42) HPGDALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL5970063 0.77 HPGD (1.00) HPGDALDH1A1HSD17B10CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2088149-A1 PHARMACOLOGICALLY ACTIVE N,N'-SUBSTITUTED 3,7-DIAZABICYCLO Ý3.3.1¨NONANES, PHARMACEUTICAL COMPOSITIONS BASED THEREON AND A METHOD FOR THE USE THEREOF Institute of Physiologically active compunds of the Russian Academy of Sciences (IPAC RAN) (RU) 2009-08-12 EP claimed
EP-2088149-A1 PHARMACOLOGICALLY ACTIVE N,N'-SUBSTITUTED 3,7-DIAZABICYCLO Ý3.3.1¨NONANES, PHARMACEUTICAL COMPOSITIONS BASED THEREON AND A METHOD FOR THE USE THEREOF Institute of Physiologically active compunds of the Russian Academy of Sciences (IPAC RAN) (RU) 2009-08-12 EP disclosed